Econic Biosciences

Curated by Signal

Developer of a platform for the discovery and development of targeted therapies for cancer

Overview

Developer of a platform for the discovery and development of targeted therapies for cancer. It uses AI to identify and characterize ecDNA which is a mediator of oncogenic gene amplification and a potent driver of tumor evolution. It enables the development of therapies that specifically target ecDNA for cancer patients.

Key facts

Founded: 2022
Headquarters: London, United Kingdom
Stage: Sign up to view
Industry: Health Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

AHA Health
App for predicting health risks
Health TechnologyLondon, United Kingdom
The Cancer App
Provider of medication adherence management solutions for cancer patients
Health TechnologyLondon, United Kingdom
Selftalk
Mental health app offering personalized cognitive behavioral therapy
Health TechnologyLondon, United Kingdom

About Econic Biosciences

What does Econic Biosciences do?

Developer of a platform for the discovery and development of targeted therapies for cancer.

Where is Econic Biosciences headquartered?

Econic Biosciences is headquartered in London, United Kingdom.

When was Econic Biosciences founded?

Econic Biosciences was founded in 2022.

Which sector is Econic Biosciences in?

Econic Biosciences operates in Health Technology.

Who are Econic Biosciences's competitors?

Companies similar to Econic Biosciences include AHA Health, The Cancer App, and Selftalk.